JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,120 | -15.1% | 1,004 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $11,917 | -1.9% | 1,004 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $12,148 | -33.3% | 1,004 | -27.4% | 0.00% | 0.0% |
| Q4 2022 | $18,201 | -2.7% | 1,382 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $18,712 | +10.9% | 1,382 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $16,874 | -14.9% | 1,382 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $19,818 | -75.0% | 1,382 | -65.5% | 0.00% | 0.0% |
| Q4 2021 | $79,137 | -8.8% | 4,011 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $86,758 | – | 4,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |